Oncology & Cancer

Immunosuppressant switch cuts skin cancer post-transplant

(HealthDay) -- In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free survival ...

Diseases, Conditions, Syndromes

Immune drug helps patients with serious kidney disorder

A drug commonly used to treat immune disorders such as lymphoma and arthritis also benefits patients with an immune disorder of the kidneys that can lead to kidney failure, according to a study appearing in an upcoming issue ...

Diseases, Conditions, Syndromes

Fingolimod: 'Hint' of advantages in a small group of patients

The immunosuppressive drug fingolimod (trade name: Gilenya) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform ...

Diseases, Conditions, Syndromes

Leukoencephalopathy risk factors ID'd for MS drug

(HealthDay) -- Drug company researchers say they've determined which multiple sclerosis patients are most vulnerable to developing a rare brain infection while taking a powerful drug called Tysabri (natalizumab).

Diseases, Conditions, Syndromes

Immune drug doesn't help kids with hard-to-treat kidney disorder

The drug rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis, has recently emerged as a potential treatment for a childhood kidney disorder known ...

Oncology & Cancer

Identifying patients who benefit most from immune suppressant

A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.

page 20 from 26